Package 0002-7597-01

{"route": ["INTRAMUSCULAR"], "spl_id": "9073f34c-307c-4a3a-8273-580ef5742229", "openfda": {"nui": ["N0000175430"], "upc": ["0300024415300", "0300024116306", "0300024115309", "0300024420304", "0300024112308", "0300024117303"], "unii": ["N7U69T4SZR"], "rxcui": ["153046", "153047", "153048", "200034", "212405", "261337", "283639", "284514", "312076", "312077", "312078", "312079", "314154", "314155", "351107", "351108", "485968", "545353", "754503", "754504", "754505", "754506"], "spl_set_id": ["d5051fbc-846b-4946-82df-341fb1216341"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0002-7597-01)  / 2 mL in 1 VIAL", "package_ndc": "0002-7597-01", "marketing_end_date": "20260630", "marketing_start_date": "20040401"}], "brand_name": "ZYPREXA Intramuscular", "product_id": "0002-7597_9073f34c-307c-4a3a-8273-580ef5742229", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "0002-7597", "generic_name": "Olanzapine", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZYPREXA", "brand_name_suffix": "Intramuscular", "active_ingredients": [{"name": "OLANZAPINE", "strength": "10 mg/2mL"}], "application_number": "NDA021253", "marketing_category": "NDA", "marketing_end_date": "20260630", "marketing_start_date": "20040401"}